✦ LIBER ✦

Dosage and duration of tamoxifen treatment for mastalgia: A controlled trial

✍ Scribed by I. S. Fentiman; M. Caleffi; H. Hamed; M. A. Chaudary

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 257 KB
Volume: 75
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800750905

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Individualized treatment duration for he

Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial

✍ Alessandra Mangia; Nicola Minerva; Donato Bacca; Raffaele Cozzolongo; Giovanni L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as effective as standard 48-week treatment. Patients (n = 696) received peginterferon alfa-2a, 180 mg/week, or peginterferon alfa-2b, 1.5 mg/kg/week, p

Use of tamoxifen in the treatment of mal

Use of tamoxifen in the treatment of malignant melanoma : Systematic review and metaanalysis of randomized controlled trials

✍ Marko B. Lens; Tony Reiman; Amna F. Husain 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

## Abstract ## BACKGROUND Tamoxifen has been used in the treatment of patients with metastatic malignant melanoma either as a single agent or, more commonly, in combination with other chemotherapeutic agents. The aim of the current study was to summarize the available clinical evidence on the role

Internet-based treatment for social phob

Internet-based treatment for social phobia: a randomized controlled trial

✍ Thomas Berger; Eléonore Hohl; Franz Caspar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 1 views

## Abstract In this study conducted in the French‐speaking part of Switzerland, 52 individuals with social phobia were randomly assigned either to an Internet‐based cognitive–behavioral treatment with minimal contact with therapists via e‐mail or to a waiting‐list control group. Significant differe

Randomized controlled trial of interfero

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

✍ Josep M. Llovet; Margarita Sala; Lluís Castells; Yanette Suarez; Ramon Vilana; L 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

The aim of this randomized controlled trial was to assess the efficacy of interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma (HCC). Fifty-eight patients with HCC who were not suitable for resection, transplantation, ethanol injection, or arterial embolization were strati

A randomized controlled trial of rituxim

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

✍ S. De Vita; L. Quartuccio; M. Isola; C. Mazzaro; P. Scaini; M. Lenzi; M. Campani 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

## Abstract ## Objective To conduct a long‐term, prospective, randomized controlled trial evaluating rituximab (RTX) therapy for severe mixed cryoglobulinemia or cryoglobulinemic vasculitis (CV). ## Methods Fifty‐nine patients with CV and related skin ulcers, active glomerulonephritis, or refrac

Rapid virological response and treatment

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Chang-Fu Chiu; Yi-Hsin C. Yang; Nai-Je 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 1 views

Recommended treatment for hepatitis C virus genotype 1 (HCV-1) patients is peginterferon plus ribavirin for 48 weeks. We assessed whether treatment duration of 24 weeks is as effective as standard treatment in HCV-1 patients with a rapid virological response (RVR; seronegative for hepatitis C virus